Should the pH of the product exceed 8.5, endothelial damage may occur, according to the literature. Because Vitrex II may not meet the predefined specification for pH, AMO is voluntarily recalling the product.
A list of affected lot numbers is available in the news release.
Read the AMO release about the Vitrex II recall (pdf).
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
